|
OMIM |
Link |
Information gain |
01 |
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
0.0270807
|
|
|
GPS
|
[NCBI]
|
0.0255888
|
|
|
storage pool platelet disease
|
[NCBI]
|
0.0084142
|
|
|
scott syndrome
|
[NCBI]
|
0.00598161
|
|
|
giant platelet syndrome
|
[NCBI]
|
0.0057405
|
|
|
QPD
|
[NCBI]
|
0.00504641
|
|
|
PF4
|
[NCBI]
|
0.00458663
|
|
|
thrombasthenia-thrombocytopenia, hereditary
|
[NCBI]
|
0.00301851
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
0.00284473
|
|
|
AUTS6
|
[NCBI]
|
0.00209301
|
|
|
prostaglandin-endoperoxide synthase deficiency
|
[NCBI]
|
0.00200927
|
|
|
HPS
|
[NCBI]
|
0.00193563
|
|
|
thrombocytopenia, autosomal recessive
|
[NCBI]
|
0.00158343
|
|
|
F3
|
[NCBI]
|
0.00152662
|
|
|
WAS
|
[NCBI]
|
0.00144791
|
|
|
MHA
|
[NCBI]
|
0.00140432
|
|
|
RA
|
[NCBI]
|
0.00105827
|
|
|
CF
|
[NCBI]
|
0.000889033
|
|
|
FTNS
|
[NCBI]
|
0.0008834
|
|
|
THC2
|
[NCBI]
|
0.000872568
|
|
|
ATHS
|
[NCBI]
|
0.000862006
|
|
|
VASP
|
[NCBI]
|
0.000786647
|
|
|
SBS
|
[NCBI]
|
0.000762952
|
|
|
epstein syndrome
|
[NCBI]
|
0.000623571
|
|
|
GP1BA
|
[NCBI]
|
0.000612831
|
|
|
PMF
|
[NCBI]
|
0.000589889
|
|
|
von willebrand disease
|
[NCBI]
|
0.000575298
|
|
|
ITGB3
|
[NCBI]
|
0.000515697
|
|
|
THC1
|
[NCBI]
|
0.000495447
|
|
|
platelet glycoprotein iv deficiency
|
[NCBI]
|
0.00047212
|
|
|
bleeding disorder due to p2ry12 defect
|
[NCBI]
|
0.000471841
|
|
|
thrombocythemia, essential
|
[NCBI]
|
0.000453556
|
|
|
visceral neuropathy, familial, autosomal recessive
|
[NCBI]
|
0.00045208
|
|
|
autism
|
[NCBI]
|
0.000431786
|
|
|
pseudo-von willebrand disease
|
[NCBI]
|
0.000401395
|
|
|
aspirin resistance
|
[NCBI]
|
0.000401395
|
|
|
CHS
|
[NCBI]
|
0.000394136
|
|
|
IS1
|
[NCBI]
|
0.000389375
|
|
|
ITGA2
|
[NCBI]
|
0.0003781
|
|
|
ITGA2B
|
[NCBI]
|
0.000376019
|
|
|
CDAN3
|
[NCBI]
|
0.000344878
|
|
|
THPO
|
[NCBI]
|
0.000341908
|
|
|
F2R
|
[NCBI]
|
0.000264632
|
|
|
TCPT
|
[NCBI]
|
0.000259374
|
|
|
glanzmann thrombasthenia, autosomal dominant
|
[NCBI]
|
0.00023585
|
|
|
bernard-soulier syndrome, benign autosomal dominant
|
[NCBI]
|
0.00023585
|
|
|
thrombocytopenia, cyclic
|
[NCBI]
|
0.00023585
|
|
|
platelet adenylate cyclase activity
|
[NCBI]
|
0.00023585
|
|
|
HPA-2
|
[NCBI]
|
0.000219647
|
|
|
MYH9
|
[NCBI]
|
0.000215871
|
|
|
TFPI
|
[NCBI]
|
0.000215269
|
|
|
hexokinase deficiency hemolytic anemia
|
[NCBI]
|
0.000194183
|
|
|
RAP1B
|
[NCBI]
|
0.000187338
|
|
|
SLC6A4
|
[NCBI]
|
0.000185778
|
|
|
thrombocytosis, benign familial microcytic
|
[NCBI]
|
0.000182192
|
|
|
CDAN2
|
[NCBI]
|
0.000170426
|
|
|
P2RY12
|
[NCBI]
|
0.0001636
|
|
|
F2RL3
|
[NCBI]
|
0.0001636
|
|
|
NGFB
|
[NCBI]
|
0.000160911
|
|
|
dyserythropoietic anemia with thrombocytopenia
|
[NCBI]
|
0.000158184
|
|
|
MPL
|
[NCBI]
|
0.000155203
|
|
|
MMRN1
|
[NCBI]
|
0.000152954
|
|
|
PFKP
|
[NCBI]
|
0.000145044
|
|
|
TNF
|
[NCBI]
|
0.000137365
|
|
|
SULT1A1
|
[NCBI]
|
0.00013333
|
|
|
APC
|
[NCBI]
|
0.000127552
|
|
|
JBS
|
[NCBI]
|
0.000126132
|
|
|
CD36
|
[NCBI]
|
0.000125553
|
|
|
TH
|
[NCBI]
|
0.000124581
|
|
|
PD
|
[NCBI]
|
0.000121337
|
|
|
primary release disorder of platelets
|
[NCBI]
|
0.000117907
|
|
|
car factor deficiency
|
[NCBI]
|
0.000117907
|
|
|
platelet signal processing defect
|
[NCBI]
|
0.000117907
|
|
|
athrombia, essential
|
[NCBI]
|
0.000117907
|
|
|
THB
|
[NCBI]
|
0.000117907
|
|
|
cyanosis and hepatic disease
|
[NCBI]
|
0.000117907
|
|
|
platelet responsiveness to adrenaline, depressed
|
[NCBI]
|
0.000117907
|
|
|
platelet prostacyclin receptor defect
|
[NCBI]
|
0.000117907
|
|
|
macrothrombocytopenia and progressive sensorineural deafness
|
[NCBI]
|
0.000117907
|
|
|
dohle bodies and leukemia
|
[NCBI]
|
0.000117907
|
|
|
giant platelet syndrome with thrombocytopenia
|
[NCBI]
|
0.000117907
|
|
|
blood group--en
|
[NCBI]
|
0.000117907
|
|
|
SELP
|
[NCBI]
|
0.000114712
|
|
|
F13A1
|
[NCBI]
|
0.00011195
|
|
|
MAOB
|
[NCBI]
|
0.000109394
|
|
|
EPO
|
[NCBI]
|
0.000106127
|
|
|
thrombocytopenia-absent radius syndrome
|
[NCBI]
|
0.000104615
|
|
|
PLCB2
|
[NCBI]
|
0.000102106
|
|
|
cyclic hematopoiesis
|
[NCBI]
|
9.76266e-05
|
|
|
TTP
|
[NCBI]
|
9.76266e-05
|
|
|
TBXA2R
|
[NCBI]
|
9.47949e-05
|
|
|
RAP2B
|
[NCBI]
|
9.36431e-05
|
|
|
SEPT5
|
[NCBI]
|
9.17583e-05
|
|
|
alcohol dependence
|
[NCBI]
|
8.71052e-05
|
|
|
GP5
|
[NCBI]
|
8.56529e-05
|
|
|
glycogen storage disease vii
|
[NCBI]
|
8.4613e-05
|
|
|
RABGGTA
|
[NCBI]
|
7.99808e-05
|
|
|
GP9
|
[NCBI]
|
7.99808e-05
|
|
|
leukocyte nuclear appendages, hereditary prevalence of
|
[NCBI]
|
7.90748e-05
|
|
|
bare lymphocyte syndrome, type i
|
[NCBI]
|
7.90748e-05
|
|
|
GUK2
|
[NCBI]
|
7.90748e-05
|
|
|
CDG2F
|
[NCBI]
|
7.90748e-05
|
|
|
afibrinogenemia, congenital
|
[NCBI]
|
7.90748e-05
|
|
|
glutamate monosodium sensitivity
|
[NCBI]
|
7.90748e-05
|
|
|
PPH1
|
[NCBI]
|
7.85054e-05
|
|
|
CJD
|
[NCBI]
|
7.8416e-05
|
|
|
GP1BB
|
[NCBI]
|
7.55499e-05
|
|
|
PLEK
|
[NCBI]
|
7.31925e-05
|
|
|
F2RL2
|
[NCBI]
|
7.19063e-05
|
|
|
AR
|
[NCBI]
|
6.87968e-05
|
|
|
FGA
|
[NCBI]
|
6.70045e-05
|
|
|
BTHS
|
[NCBI]
|
6.6616e-05
|
|
|
MDD
|
[NCBI]
|
6.61508e-05
|
|
|
PPBP
|
[NCBI]
|
6.61183e-05
|
|
|
ALD
|
[NCBI]
|
6.56405e-05
|
|
|
CAMT
|
[NCBI]
|
6.46946e-05
|
|
|
GATA1
|
[NCBI]
|
6.37388e-05
|
|
|
CD151
|
[NCBI]
|
6.37373e-05
|
|
|
AP3B1
|
[NCBI]
|
5.96703e-05
|
|
|
carnitine palmitoyltransferase ii deficiency, late-onset
|
[NCBI]
|
5.96375e-05
|
|
|
GP6
|
[NCBI]
|
5.94854e-05
|
|
|
PLG
|
[NCBI]
|
5.76937e-05
|
|
|
PRL
|
[NCBI]
|
5.62929e-05
|
|
|
THBS1
|
[NCBI]
|
5.62787e-05
|
|
|
platelet disorder, familial, with associated myeloid malignancy
|
[NCBI]
|
5.5512e-05
|
|
|
WAS
|
[NCBI]
|
5.43733e-05
|
|
|
GLS
|
[NCBI]
|
5.33148e-05
|
|
|
ND
|
[NCBI]
|
5.18668e-05
|
|
|
MAFK
|
[NCBI]
|
4.90929e-05
|
|
|
NFE2
|
[NCBI]
|
4.90929e-05
|
|
|
PCNA
|
[NCBI]
|
4.89447e-05
|
|
|
LAT
|
[NCBI]
|
4.88815e-05
|
|
|
CD47
|
[NCBI]
|
4.86484e-05
|
|
|
homocystinuria
|
[NCBI]
|
4.69992e-05
|
|
|
ITGB1
|
[NCBI]
|
4.65557e-05
|
|
|
MAFG
|
[NCBI]
|
4.58679e-05
|
|
|
ALOX12
|
[NCBI]
|
4.58679e-05
|
|
|
P2RX1
|
[NCBI]
|
4.58679e-05
|
|
|
CFTR
|
[NCBI]
|
4.5805e-05
|
|
|
GSN
|
[NCBI]
|
4.56168e-05
|
|
|
autoimmune disease
|
[NCBI]
|
4.35377e-05
|
|
|
elejalde disease
|
[NCBI]
|
4.35377e-05
|
|
|
COMT
|
[NCBI]
|
4.20113e-05
|
|
|
ENTPD1
|
[NCBI]
|
4.10633e-05
|
|
|
PRG1
|
[NCBI]
|
4.10633e-05
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
4.02367e-05
|
|
|
PTK2
|
[NCBI]
|
3.98041e-05
|
|
|
dopamine beta-hydroxylase deficiency, congenital
|
[NCBI]
|
3.92383e-05
|
|
|
kawasaki disease
|
[NCBI]
|
3.92383e-05
|
|
|
intestinal pseudoobstruction, neuronal, chronic idiopathic, x-linked
|
[NCBI]
|
3.92383e-05
|
|
|
erythermalgia, primary
|
[NCBI]
|
3.92383e-05
|
|
|
TPH1
|
[NCBI]
|
3.91732e-05
|
|
|
RP
|
[NCBI]
|
3.90772e-05
|
|
|
FA
|
[NCBI]
|
3.75718e-05
|
|
|
GNAQ
|
[NCBI]
|
3.75137e-05
|
|
|
F2
|
[NCBI]
|
3.75137e-05
|
|
|
JAK2
|
[NCBI]
|
3.68041e-05
|
|
|
amyloidosis vi
|
[NCBI]
|
3.66659e-05
|
|
|
BLOC1S2
|
[NCBI]
|
3.65934e-05
|
|
|
platelet receptor for type iii collagen, 47-kd
|
[NCBI]
|
3.65934e-05
|
|
|
platelet endothelial aggregation receptor 1
|
[NCBI]
|
3.65934e-05
|
|
|
PFN1
|
[NCBI]
|
3.60353e-05
|
|
|
CPB2
|
[NCBI]
|
3.57815e-05
|
|
|
CDG2A
|
[NCBI]
|
3.56217e-05
|
|
|
temporal arteritis
|
[NCBI]
|
3.41113e-05
|
|
|
LPL
|
[NCBI]
|
3.37133e-05
|
|
|
PTK2B
|
[NCBI]
|
3.35716e-05
|
|
|
HPS2
|
[NCBI]
|
3.25156e-05
|
|
|
homocysteinemia
|
[NCBI]
|
3.25156e-05
|
|
|
hemangioma-thrombocytopenia syndrome
|
[NCBI]
|
3.25156e-05
|
|
|
RAB27A
|
[NCBI]
|
3.2381e-05
|
|
|
PROS1
|
[NCBI]
|
3.2381e-05
|
|
|
factor v deficiency
|
[NCBI]
|
3.13564e-05
|
|
|
VIP
|
[NCBI]
|
3.11803e-05
|
|
|
ABL
|
[NCBI]
|
2.98512e-05
|
|
|
CVID
|
[NCBI]
|
2.97353e-05
|
|
|
GLUD1
|
[NCBI]
|
2.95199e-05
|
|
|
PTGS1
|
[NCBI]
|
2.95199e-05
|
|
|
LTC4S
|
[NCBI]
|
2.95199e-05
|
|
|
MAPK1
|
[NCBI]
|
2.90227e-05
|
|
|
CD40
|
[NCBI]
|
2.86904e-05
|
|
|
GNAS
|
[NCBI]
|
2.86417e-05
|
|
|
HLA-A
|
[NCBI]
|
2.82787e-05
|
|
|
DLD
|
[NCBI]
|
2.79111e-05
|
|
|
MTCO2
|
[NCBI]
|
2.79111e-05
|
|
|
NPY
|
[NCBI]
|
2.72202e-05
|
|
|
SNAPAP
|
[NCBI]
|
2.66546e-05
|
|
|
ADCY7
|
[NCBI]
|
2.66546e-05
|
|
|
LTBP1
|
[NCBI]
|
2.66546e-05
|
|
|
BLOC1S3
|
[NCBI]
|
2.66546e-05
|
|
|
MUTED
|
[NCBI]
|
2.66546e-05
|
|
|
NAPG
|
[NCBI]
|
2.66546e-05
|
|
|
PIK3CB
|
[NCBI]
|
2.66546e-05
|
|
|
INPP5B
|
[NCBI]
|
2.66546e-05
|
|
|
C1GALT1
|
[NCBI]
|
2.66546e-05
|
|
|
SULT2B1
|
[NCBI]
|
2.66546e-05
|
|
|
MTND6
|
[NCBI]
|
2.64818e-05
|
|
|
FMF
|
[NCBI]
|
2.63906e-05
|
|
|
AFP
|
[NCBI]
|
2.59744e-05
|
|
|
MTCO1
|
[NCBI]
|
2.51976e-05
|
|
|
RASA1
|
[NCBI]
|
2.50721e-05
|
|
|
HK1
|
[NCBI]
|
2.46018e-05
|
|
|
MBP
|
[NCBI]
|
2.44675e-05
|
|
|
TNFSF6
|
[NCBI]
|
2.43942e-05
|
|
|
LAD
|
[NCBI]
|
2.40007e-05
|
|
|
MTATP6
|
[NCBI]
|
2.34898e-05
|
|
|
AP3D1
|
[NCBI]
|
2.29312e-05
|
|
|
UNC13D
|
[NCBI]
|
2.29312e-05
|
|
|
PLDN
|
[NCBI]
|
2.29312e-05
|
|
|
CNO
|
[NCBI]
|
2.29312e-05
|
|
|
CIB1
|
[NCBI]
|
2.29312e-05
|
|
|
STXBP3
|
[NCBI]
|
2.29312e-05
|
|
|
EPR1
|
[NCBI]
|
2.29312e-05
|
|
|
PLA1A
|
[NCBI]
|
2.29312e-05
|
|
|
PIP5K2A
|
[NCBI]
|
2.29312e-05
|
|
|
RPS27A
|
[NCBI]
|
2.29312e-05
|
|
|
septin 8
|
[NCBI]
|
2.29312e-05
|
|
|
INPP4A
|
[NCBI]
|
2.29312e-05
|
|
|
SDPR
|
[NCBI]
|
2.29312e-05
|
|
|
PF4V1
|
[NCBI]
|
2.29312e-05
|
|
|
CD109
|
[NCBI]
|
2.29312e-05
|
|
|
PABPC4
|
[NCBI]
|
2.29312e-05
|
|
|
VAMP3
|
[NCBI]
|
2.29312e-05
|
|
|
ZYX
|
[NCBI]
|
2.29312e-05
|
|
|
PDE3A
|
[NCBI]
|
2.29312e-05
|
|
|
lecithin:cholesterol acyltransferase deficiency
|
[NCBI]
|
2.16224e-05
|
|
|
HGF
|
[NCBI]
|
2.10675e-05
|
|
|
PTH
|
[NCBI]
|
2.082e-05
|
|
|
TBXAS1
|
[NCBI]
|
2.05289e-05
|
|
|
BLOC1S1
|
[NCBI]
|
2.05289e-05
|
|
|
TREML1
|
[NCBI]
|
2.05289e-05
|
|
|
CLN2
|
[NCBI]
|
2.05289e-05
|
|
|
CD63
|
[NCBI]
|
2.05289e-05
|
|
|
HTR2B
|
[NCBI]
|
2.05289e-05
|
|
|
IMPA1
|
[NCBI]
|
2.05289e-05
|
|
|
B4GALNT2
|
[NCBI]
|
2.05289e-05
|
|
|
ABCA1
|
[NCBI]
|
2.02465e-05
|
|
|
TPI1
|
[NCBI]
|
2.02465e-05
|
|
|
MCP
|
[NCBI]
|
2.01195e-05
|
|
|
HRG
|
[NCBI]
|
1.94626e-05
|
|
|
SPP1
|
[NCBI]
|
1.94267e-05
|
|
|
CCL22
|
[NCBI]
|
1.91715e-05
|
|
|
ACTR3
|
[NCBI]
|
1.87541e-05
|
|
|
JAM3
|
[NCBI]
|
1.87541e-05
|
|
|
RFXAP
|
[NCBI]
|
1.87541e-05
|
|
|
STE
|
[NCBI]
|
1.87541e-05
|
|
|
NAPA
|
[NCBI]
|
1.87541e-05
|
|
|
ABAT
|
[NCBI]
|
1.87541e-05
|
|
|
FUCA2
|
[NCBI]
|
1.87541e-05
|
|
|
PDIA6
|
[NCBI]
|
1.87541e-05
|
|
|
ZFPM1
|
[NCBI]
|
1.87541e-05
|
|
|
SCZD1
|
[NCBI]
|
1.85964e-05
|
|
|
methemoglobinemia due to deficiency of methemoglobin reductase
|
[NCBI]
|
1.80395e-05
|
|
|
THBS2
|
[NCBI]
|
1.73489e-05
|
|
|
CD24
|
[NCBI]
|
1.73489e-05
|
|
|
PRKG1
|
[NCBI]
|
1.73489e-05
|
|
|
ITGAM
|
[NCBI]
|
1.73489e-05
|
|
|
GNA13
|
[NCBI]
|
1.73489e-05
|
|
|
ADRA2A
|
[NCBI]
|
1.73489e-05
|
|
|
FGB
|
[NCBI]
|
1.73489e-05
|
|
|
CMDD
|
[NCBI]
|
1.72693e-05
|
|
|
AHO
|
[NCBI]
|
1.72313e-05
|
|
|
WASL
|
[NCBI]
|
1.61878e-05
|
|
|
ACTR2
|
[NCBI]
|
1.61878e-05
|
|
|
LCP2
|
[NCBI]
|
1.61878e-05
|
|
|
PGAM1
|
[NCBI]
|
1.52003e-05
|
|
|
C1QR1
|
[NCBI]
|
1.52003e-05
|
|
|
PECAM1
|
[NCBI]
|
1.52003e-05
|
|
|
VCL
|
[NCBI]
|
1.52003e-05
|
|
|
ATP2A3
|
[NCBI]
|
1.52003e-05
|
|
|
glycogen storage disease ib
|
[NCBI]
|
1.49166e-05
|
|
|
EGF
|
[NCBI]
|
1.43525e-05
|
|
|
BCL2L1
|
[NCBI]
|
1.43426e-05
|
|
|
AKT2
|
[NCBI]
|
1.43426e-05
|
|
|
OCRL
|
[NCBI]
|
1.43426e-05
|
|
|
BAIAP2
|
[NCBI]
|
1.43426e-05
|
|
|
LAG5
|
[NCBI]
|
1.43426e-05
|
|
|
FGG
|
[NCBI]
|
1.43426e-05
|
|
|
GAS6
|
[NCBI]
|
1.43426e-05
|
|
|
CD9
|
[NCBI]
|
1.43426e-05
|
|
|
NPPA
|
[NCBI]
|
1.40552e-05
|
|
|
SLC18A2
|
[NCBI]
|
1.39192e-05
|
|
|
PCI
|
[NCBI]
|
1.39192e-05
|
|
|
ITGB2
|
[NCBI]
|
1.39192e-05
|
|
|
aHUS
|
[NCBI]
|
1.38696e-05
|
|
|
SLC6A3
|
[NCBI]
|
1.35961e-05
|
|
|
SULT1A3
|
[NCBI]
|
1.35856e-05
|
|
|
CXCL10
|
[NCBI]
|
1.35856e-05
|
|
|
ENAH
|
[NCBI]
|
1.29091e-05
|
|
|
HPS1
|
[NCBI]
|
1.29091e-05
|
|
|
FCGR2B
|
[NCBI]
|
1.29091e-05
|
|
|
SELL
|
[NCBI]
|
1.29091e-05
|
|
|
SDHC
|
[NCBI]
|
1.29091e-05
|
|
|
HTR2A
|
[NCBI]
|
1.29091e-05
|
|
|
FYB
|
[NCBI]
|
1.29091e-05
|
|
|
pta deficiency
|
[NCBI]
|
1.22984e-05
|
|
|
MSN
|
[NCBI]
|
1.22984e-05
|
|
|
TAP1
|
[NCBI]
|
1.22984e-05
|
|
|
mucopolysaccharidosis type vi
|
[NCBI]
|
1.19925e-05
|
|
|
MTND4L
|
[NCBI]
|
1.17424e-05
|
|
|
FLI1
|
[NCBI]
|
1.17424e-05
|
|
|
mucopolysaccharidosis type vii
|
[NCBI]
|
1.11491e-05
|
|
|
HPSE
|
[NCBI]
|
1.07628e-05
|
|
|
ACTC1
|
[NCBI]
|
1.07628e-05
|
|
|
ACTB
|
[NCBI]
|
1.07628e-05
|
|
|
PFKL
|
[NCBI]
|
1.07628e-05
|
|
|
SELE
|
[NCBI]
|
1.07628e-05
|
|
|
refsum disease, infantile form
|
[NCBI]
|
1.03618e-05
|
|
|
ANXA5
|
[NCBI]
|
1.03272e-05
|
|
|
MTND2
|
[NCBI]
|
1.03272e-05
|
|
|
TAZ
|
[NCBI]
|
1.03272e-05
|
|
|
ACP5
|
[NCBI]
|
1.00764e-05
|
|
|
CST3
|
[NCBI]
|
9.92163e-06
|
|
|
MME
|
[NCBI]
|
9.92163e-06
|
|
|
EPB42
|
[NCBI]
|
9.92163e-06
|
|
|
HSPCA
|
[NCBI]
|
9.92163e-06
|
|
|
IL3
|
[NCBI]
|
9.615e-06
|
|
|
ABO
|
[NCBI]
|
9.54262e-06
|
|
|
MYB
|
[NCBI]
|
9.54262e-06
|
|
|
MTCO3
|
[NCBI]
|
9.54262e-06
|
|
|
MTND3
|
[NCBI]
|
9.18719e-06
|
|
|
XK
|
[NCBI]
|
8.85284e-06
|
|
|
ATP2A2
|
[NCBI]
|
8.85284e-06
|
|
|
MTND5
|
[NCBI]
|
8.85284e-06
|
|
|
CRC
|
[NCBI]
|
8.57475e-06
|
|
|
NPC1
|
[NCBI]
|
8.53747e-06
|
|
|
PPARA
|
[NCBI]
|
8.487e-06
|
|
|
AD
|
[NCBI]
|
8.42631e-06
|
|
|
CDG1A
|
[NCBI]
|
8.29213e-06
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i
|
[NCBI]
|
8.29213e-06
|
|
|
transcobalamin ii deficiency
|
[NCBI]
|
8.23927e-06
|
|
|
PAI1
|
[NCBI]
|
8.23927e-06
|
|
|
PLSCR1
|
[NCBI]
|
8.23927e-06
|
|
|
OSBP
|
[NCBI]
|
8.23927e-06
|
|
|
ALPS
|
[NCBI]
|
8.03129e-06
|
|
|
VRNI
|
[NCBI]
|
7.99043e-06
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
7.95667e-06
|
|
|
CAT
|
[NCBI]
|
7.72459e-06
|
|
|
NSF
|
[NCBI]
|
7.72397e-06
|
|
|
mitochondrial complex iv deficiency
|
[NCBI]
|
7.68749e-06
|
|
|
MTTK
|
[NCBI]
|
7.43303e-06
|
|
|
INPP5D
|
[NCBI]
|
7.43303e-06
|
|
|
CD59
|
[NCBI]
|
7.18975e-06
|
|
|
PPIB
|
[NCBI]
|
7.18975e-06
|
|
|
ALDH2
|
[NCBI]
|
6.95756e-06
|
|
|
VEGF
|
[NCBI]
|
6.8052e-06
|
|
|
FGF7
|
[NCBI]
|
6.72253e-06
|
|
|
NCOA3
|
[NCBI]
|
6.52325e-06
|
|
|
CD40LG
|
[NCBI]
|
6.52325e-06
|
|
|
FN1
|
[NCBI]
|
6.31973e-06
|
|
|
MTND4
|
[NCBI]
|
6.31973e-06
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
6.31973e-06
|
|
|
ADORA3
|
[NCBI]
|
6.31973e-06
|
|
|
fucosidosis
|
[NCBI]
|
6.31973e-06
|
|
|
G6PD
|
[NCBI]
|
6.26642e-06
|
|
|
ILK
|
[NCBI]
|
6.19624e-06
|
|
|
TFR2
|
[NCBI]
|
6.1245e-06
|
|
|
ACE
|
[NCBI]
|
6.07357e-06
|
|
|
AGTR1
|
[NCBI]
|
5.93701e-06
|
|
|
GPX1
|
[NCBI]
|
5.93701e-06
|
|
|
MBL2
|
[NCBI]
|
5.87187e-06
|
|
|
CXCL12
|
[NCBI]
|
5.75679e-06
|
|
|
MTCYB
|
[NCBI]
|
5.75679e-06
|
|
|
RCDP1
|
[NCBI]
|
5.61939e-06
|
|
|
PAFAH1B1
|
[NCBI]
|
5.41642e-06
|
|
|
ADCYAP1
|
[NCBI]
|
5.41607e-06
|
|
|
MTND1
|
[NCBI]
|
5.10029e-06
|
|
|
INHBA
|
[NCBI]
|
5.10029e-06
|
|
|
CXCR4
|
[NCBI]
|
5.10029e-06
|
|
|
RUNX1
|
[NCBI]
|
5.10029e-06
|
|
|
SLC1A2
|
[NCBI]
|
4.80583e-06
|
|
|
TPT1
|
[NCBI]
|
4.80583e-06
|
|
|
DSTN
|
[NCBI]
|
4.66602e-06
|
|
|
BDNF
|
[NCBI]
|
4.63078e-06
|
|
|
HIGM1
|
[NCBI]
|
4.37674e-06
|
|
|
SEMA3A
|
[NCBI]
|
4.27341e-06
|
|
|
PROCR
|
[NCBI]
|
4.15079e-06
|
|
|
mannosidosis, alpha b, lysosomal
|
[NCBI]
|
4.01215e-06
|
|
|
NOS3
|
[NCBI]
|
3.91679e-06
|
|
|
ABCC1
|
[NCBI]
|
3.87608e-06
|
|
|
MDLS
|
[NCBI]
|
3.67006e-06
|
|
|
RNASE3
|
[NCBI]
|
3.56929e-06
|
|
|
FLNA
|
[NCBI]
|
3.48943e-06
|
|
|
CFH
|
[NCBI]
|
3.48943e-06
|
|
|
APP
|
[NCBI]
|
3.38779e-06
|
|
|
APOE
|
[NCBI]
|
3.33925e-06
|
|
|
FRAP1
|
[NCBI]
|
3.33895e-06
|
|
|
MAOA
|
[NCBI]
|
3.20029e-06
|
|
|
MMP2
|
[NCBI]
|
3.20029e-06
|
|
|
TF
|
[NCBI]
|
3.13518e-06
|
|
|
IL2
|
[NCBI]
|
2.99508e-06
|
|
|
TGFB1
|
[NCBI]
|
2.85096e-06
|
|
|
SCIDX1
|
[NCBI]
|
2.76713e-06
|
|
|
STAT3
|
[NCBI]
|
2.55041e-06
|
|
|
HDC
|
[NCBI]
|
2.46608e-06
|
|
|
LCN2
|
[NCBI]
|
2.46464e-06
|
|
|
GHRH
|
[NCBI]
|
2.43387e-06
|
|
|
HBA1
|
[NCBI]
|
2.39335e-06
|
|
|
IFNA1
|
[NCBI]
|
2.25625e-06
|
|
|
SPARC
|
[NCBI]
|
2.00243e-06
|
|
|
TNFRSF11B
|
[NCBI]
|
1.83817e-06
|
|
|
LCAT
|
[NCBI]
|
1.80085e-06
|
|
|
CCL2
|
[NCBI]
|
1.77322e-06
|
|
|
CCL17
|
[NCBI]
|
1.77322e-06
|
|
|
CLU
|
[NCBI]
|
1.71944e-06
|
|
|
PAEP
|
[NCBI]
|
1.51731e-06
|
|
|
CMH
|
[NCBI]
|
1.48579e-06
|
|
|
leber optic atrophy
|
[NCBI]
|
1.48579e-06
|
|
|
ALB
|
[NCBI]
|
1.388e-06
|
|
|
LRP1
|
[NCBI]
|
1.29244e-06
|
|
|
TNFSF10
|
[NCBI]
|
1.25488e-06
|
|
|
ACPP
|
[NCBI]
|
1.19925e-06
|
|
|
AVP
|
[NCBI]
|
1.16687e-06
|
|
|
CP
|
[NCBI]
|
1.10614e-06
|
|
|
BTK
|
[NCBI]
|
1.09209e-06
|
|
|
TLR4
|
[NCBI]
|
1.01806e-06
|
|
|
SCZD
|
[NCBI]
|
9.57137e-07
|
|
|
GUSB
|
[NCBI]
|
8.21077e-07
|
|
|
ADA
|
[NCBI]
|
7.89882e-07
|
|
|
fabry disease
|
[NCBI]
|
7.58619e-07
|
|
|
ACHE
|
[NCBI]
|
5.79733e-07
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
4.95549e-07
|
|
|
PLAUR
|
[NCBI]
|
4.64266e-07
|
|
|
PRKCM
|
[NCBI]
|
4.23685e-07
|
|
|
SLE
|
[NCBI]
|
4.2175e-07
|
|
|
MPO
|
[NCBI]
|
2.69898e-07
|
|
|
KDR
|
[NCBI]
|
2.54002e-07
|
|
|
COMP
|
[NCBI]
|
2.40678e-07
|
|
|
BCR
|
[NCBI]
|
2.11867e-07
|
|
|
PEDF
|
[NCBI]
|
1.75923e-07
|
|
|
CGD
|
[NCBI]
|
1.54307e-07
|
|
|
SLPI
|
[NCBI]
|
1.43377e-07
|
|
|
BCHE
|
[NCBI]
|
1.05941e-07
|
|
|
GPI
|
[NCBI]
|
9.9142e-08
|
|
|
SST
|
[NCBI]
|
9.9142e-08
|
|
|
HBB
|
[NCBI]
|
9.9142e-08
|
|
|
ABP1
|
[NCBI]
|
9.25458e-08
|
|
|
SDC2
|
[NCBI]
|
6.64264e-08
|
|
|
GTS
|
[NCBI]
|
5.6073e-08
|
|
|
CTGF
|
[NCBI]
|
4.95399e-08
|
|
|
HP
|
[NCBI]
|
4.26808e-08
|
|
|
velocardiofacial syndrome
|
[NCBI]
|
2.80001e-08
|
|
|
NPC1
|
[NCBI]
|
1.62733e-08
|
|
|
SCA1
|
[NCBI]
|
1.62733e-08
|
|
|
FRDA
|
[NCBI]
|
1.20041e-08
|
|
|
GAPDH
|
[NCBI]
|
8.17191e-09
|
|
|
XDH
|
[NCBI]
|
7.61898e-09
|
|
|
APOB
|
[NCBI]
|
3.17305e-09
|
|
|
FAAH
|
[NCBI]
|
1.67111e-10
|
|
|
NGFR
|
[NCBI]
|
1.25765e-12
|
|